{"DataElement":{"publicId":"13751657","version":"1","preferredName":"Modified Toxicity Criteria Fever Without Infection Disorder Condition Grade","preferredDefinition":"A description of the modified toxicity criteria for fever without infection grade.","longName":"13751562v1.00:13751565v1.00","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"13751562","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria Fever Without Infectious Disorder Condition","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.:Elevation of body temperature above normal due to inflammatory or immune responses._Used to indicate the absence or lack of something or someone._A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact._A state of being, such as a state of health.","longName":"13751560v1.00:13751561v1.00","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"13751560","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.","longName":"C199478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Marrow Donor Program Modified Toxicity Criteria","conceptCode":"C199478","definition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED37C0-8F10-1878-E053-731AD00AD0C4","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13751561","version":"1","preferredName":"Fever Without Infectious Disorder Condition","preferredDefinition":"Elevation of body temperature above normal due to inflammatory or immune responses._Used to indicate the absence or lack of something or someone._A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact._A state of being, such as a state of health.","longName":"C3038:C25718:C26726:C25457","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Condition","conceptCode":"C25457","definition":"A state of being, such as a state of health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED37C0-8F11-1878-E053-731AD00AD0C4","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED37C0-8F12-1878-E053-731AD00AD0C4","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13751565","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria Fever Grade","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain._Elevation of body temperature above normal due to inflammatory or immune responses._A position on a scale of intensity or amount or quality.","longName":"13751565v1.00","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"120","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":null,"ValueMeaning":{"publicId":"13707077","version":"1","preferredName":"None","longName":"13707077v1.00","preferredDefinition":"None (grade 0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC997DFD-C173-2136-E053-731AD00AF445","latestVersionIndicator":"Yes","beginDate":"2023-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-26","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCED5D28-F8B9-1D3B-E053-731AD00AFD19","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"38.0 - 39.0° C / 100.0 - 102.2° F","valueDescription":null,"ValueMeaning":{"publicId":"13751612","version":"1","preferredName":"38.0 - 39.0° C / 100.0 - 102.2° F","longName":"13751612v1.00","preferredDefinition":"38.0 - 39.0° C / 100.0 - 102.2° F (grade 1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED5D28-F8B5-1D3B-E053-731AD00AFD19","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCED5D28-F8BA-1D3B-E053-731AD00AFD19","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Greater than 39.0 - 40.0° C / 102.2 - 104.0° F","valueDescription":null,"ValueMeaning":{"publicId":"13751613","version":"1","preferredName":"Greater than 39.0 - 40.0° C / 102.2 - 104.0° F","longName":"13751613v1.00","preferredDefinition":"Greater than 39.0 - 40.0° C / 102.2 - 104.0° F (grade 2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED5D28-F8B6-1D3B-E053-731AD00AFD19","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCED5D28-F8BB-1D3B-E053-731AD00AFD19","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Greater than 40.0° C / 104.0° F for less than 24 hours","valueDescription":null,"ValueMeaning":{"publicId":"13751614","version":"1","preferredName":"Greater than 40.0° C / 104.0° F for less than 24 hours","longName":"13751614v1.00","preferredDefinition":"Greater than 40.0° C / 104.0° F for less than 24 hours (grade 3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED5D28-F8B7-1D3B-E053-731AD00AFD19","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCED5D28-F8BC-1D3B-E053-731AD00AFD19","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Greater than 40.0° C / 104.0° F for more than 24 hours","valueDescription":null,"ValueMeaning":{"publicId":"13751615","version":"1","preferredName":"Greater than 40.0° C / 104.0° F for more than 24 hours","longName":"13751615v1.00","preferredDefinition":"Greater than 40.0° C / 104.0° F for more than 24 hours (grade 4)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED5D28-F8B8-1D3B-E053-731AD00AFD19","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCED5D28-F8BD-1D3B-E053-731AD00AFD19","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13751696","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria Fever Grade","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain._Elevation of body temperature above normal due to inflammatory or immune responses._A position on a scale of intensity or amount or quality.","longName":"13751696v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Marrow Donor Program Modified Toxicity Criteria","conceptCode":"C199478","definition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEDD26C-C4DE-2F8B-E053-731AD00A1266","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED4147-8855-19D9-E053-731AD00A441B","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak2023.5.30 Created per ticket request CADSR0002455. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the modified toxicity criteria fever without infection grade?","url":null,"context":"NHLBI"},{"name":"NMDP Text 1","type":"Application Standard Question Text","description":"Fever in absence of infections","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED7A21-C04F-2145-E053-731AD00ADAF2","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"}}